Kubasch AS, Peterlin P, Cluzeau T, Gotze KS, et al. Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial. Leukemia 2023 Sep 21. doi: 10.1038/s41375-023-02029.
PMID: 37735558